#United States #Veeva Systems #CRM Technology #Pleasanton #Bristol-Myers Squibb

Bristol-Myers Squibb Adopts Veeva Vault CRM

Bristol-Myers Squibb (BMS) has officially decided to incorporate Veeva Vault CRM into its operational framework. This decision highlights the company's commitment to leveraging technological advancements to improve interactions with healthcare professionals and patients.

According to Greg Meyers, BMS's Executive Vice President and Chief Digital & Technology Officer, technology is fundamentally altering the way they engage with customers and patients. He expressed enthusiasm about utilizing Vault CRM, explaining that it would provide healthcare professionals with the necessary resources to make informed decisions regarding innovative and increasingly complex drugs available today.

Meyers further elaborated on the importance of integrating AI throughout every touchpoint in the customer experience. From how healthcare professionals receive valuable information about BMS’s portfolio to interactions with sales representatives, the incorporation of AI is seen as key in their mission to deliver life-changing medications to patients around the world.

Peter Gassner, CEO of Veeva Systems, reinforced the significance of this partnership, stating his gratitude for BMS's trust and collaboration. He emphasized that Veeva is dedicated to supporting BMS in its mission to provide medications that transform the lives of patients suffering from serious conditions. The implementation of Vault CRM is designed to enhance engagement with healthcare professionals through next-generation CRM tools that incorporate AI agents, facilitating faster delivery of appropriate treatments to patients.

Veeva Vault CRM includes a suite of applications aimed at creating a robust technological foundation for commercial activities. Notably, the first AI agents tailored for Vault CRM, such as Pre-call Agent, Content Agent, Free Text Agent, and Voice Agent, are set to be launched by December 2025.

Veeva Systems specializes in providing cloud services tailored to the life sciences industry through software, data, and business consulting. With a focus on innovation and customer success, they serve over 1,500 clients ranging from the world's largest biopharmaceutical companies to emerging biotechnology firms. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, and shareholders.

For more information about Veeva, visit Veeva's official website.

Additionally, individuals can follow Veeva on LinkedIn to stay updated with the latest company news.

Forward-Looking Statements

This article includes forward-looking statements regarding Veeva’s products and services and the expected results or benefits arising from their use. These statements reflect current expectations and actual outcomes may differ materially due to various risks. For a comprehensive overview of these risks, please refer to our filings with the SEC.